Annals of Clinical Microbiology and Antimicrobials (May 2020)
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
- Khan Sharun,
- Kuldeep Dhama,
- Shailesh Kumar Patel,
- Mamta Pathak,
- Ruchi Tiwari,
- Bhoj Raj Singh,
- Ranjit Sah,
- D. Katterine Bonilla-Aldana,
- Alfonso J. Rodriguez-Morales,
- Hakan Leblebicioglu
Affiliations
- Khan Sharun
- Division of Surgery, ICAR-Indian Veterinary Research Institute
- Kuldeep Dhama
- Division of Pathology, ICAR-Indian Veterinary Research Institute
- Shailesh Kumar Patel
- Division of Pathology, ICAR-Indian Veterinary Research Institute
- Mamta Pathak
- Division of Pathology, ICAR-Indian Veterinary Research Institute
- Ruchi Tiwari
- Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU)
- Bhoj Raj Singh
- Division of Epidemiology, ICAR-Indian Veterinary Research Institute
- Ranjit Sah
- Department of Microbiology, Institute of Medicine, Tribhuvan University Teaching Hospital
- D. Katterine Bonilla-Aldana
- Semillero de Zoonosis, Grupo de Investigación BIOECOS, Fundación Universitaria Autónoma de las Américas
- Alfonso J. Rodriguez-Morales
- Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira
- Hakan Leblebicioglu
- Department of Infectious Diseases, Samsun Liv Hospital
- DOI
- https://doi.org/10.1186/s12941-020-00368-w
- Journal volume & issue
-
Vol. 19,
no. 1
pp. 1 – 5
Abstract
No abstracts available.Keywords
